“The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other [pharmacy benefit managers], demonstrates clear ideological bias and advances a false and damaging narrative—narrative that could harm the health care system by removing essential checks and balances which would result in higher drug prices for American consumers,” The Cigna Group Chief Legal Officer Andrea Nelson said.
Cigna subsidiary Express Scripts Inc. claimed the Federal Trade Commission’s July interim report—which claims middlemen have driven up prescription drug costs and exacerbated independent pharmacies—is false and misleading.
In the Eastern District of Missouri, Express Scripts filed a lawsuit against the FTC and Lina M. Khan, the chair of the FTC, demanding declaratory and injunctive relief to vacate and remove the report. Express Scripts maintains in the complaint that the report is “unfair, biased, erroneous and defamatory.”
